Patents by Inventor Dawson James Reimer

Dawson James Reimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140100537
    Abstract: The present invention provides a titratable transdermal drug delivery system comprising an effective dose of an antithrombotic agent, such as tirofiban, or a pharmaceutically acceptable salt thereof. The dosage of the drug delivered is proportional to the size of the patch applied and achieves 60-85% platelet inhibition. The system enables and individualized treatment for patients. Also provided are methods for the treatment of various disorders where platelet inhibition is desired.
    Type: Application
    Filed: December 11, 2013
    Publication date: April 10, 2014
    Applicant: MEDICURE INTERNATIONAL INC.
    Inventors: George Roby THOMAS, Dawson James REIMER, Albert D. FRIESEN
  • Publication number: 20120029447
    Abstract: The present invention provides a titratable transdermal drug delivery system comprising an effective dose of an antithrombotic agent, such as tirofiban, or a pharmaceutically acceptable salt thereof. The dosage of the drug delivered is proportional to the size of the patch applied and achieves 60-85% platelet inhibition. The system enables and individualized treatment for patients. Also provided are methods for the treatment of various disorders where platelet inhibition is desired.
    Type: Application
    Filed: March 18, 2010
    Publication date: February 2, 2012
    Applicant: Medicure International Inc.
    Inventors: George Roby Thomas, Dawson James Reimer, Albert D. Friesen
  • Publication number: 20100196342
    Abstract: This invention relates to improvement of mood, memory and cognitive function with administration of pyridoxal 5?-phosphate. Also provided is the use of pyridoxal 5?-phosphate for the preparation of a medicament for the improvement of mood, memory and cognitive function, and kits comprising pyridoxal 5?-phosphate for the same purpose.
    Type: Application
    Filed: May 28, 2008
    Publication date: August 5, 2010
    Inventors: Albert Friesen, Dawson James Reimer
  • Publication number: 20100197635
    Abstract: This invention relates to treatment of Tardive Dyskinesia through the administration of pyridoxal 5?-phosphate. The treatment may be an oral administration of 100-4000 mg/day, for example, 100-750 mg/day or about 250 mg/day. Also provided is the use of pyridoxal 5?-phosphate for the preparation of a medicament for the treatment of tardive dyskinesia, kits comprising pyridoxal 5?-phosphate for the treatment of tardive dyskinesia, and combination drugs for the treatment of tardive dyskinesia.
    Type: Application
    Filed: May 28, 2008
    Publication date: August 5, 2010
    Inventors: Albert Friesen, Dawson James Reimer